The estimated Net Worth of Donald J. Jr. La Bauve is at least $1.22 Millón dollars as of 26 February 2019. Donald Bauve owns over 1,990 units of Albemarle stock worth over $687,878 and over the last 12 years Donald sold ALB stock worth over $537,024.
Donald has made over 16 trades of the Albemarle stock since 2013, according to the Form 4 filled with the SEC. Most recently Donald exercised 1,990 units of ALB stock worth $120,674 on 26 February 2019.
The largest trade Donald's ever made was selling 3,564 units of Albemarle stock on 12 May 2016 worth over $268,512. On average, Donald trades about 1,233 units every 122 days since 2013. As of 26 February 2019 Donald still owns at least 7,703 units of Albemarle stock.
You can see the complete history of Donald Bauve stock trades at the bottom of the page.
Donald's mailing address filed with the SEC is ALBEMARLE CORPORATION, 451 FLORIDA STREET, BATON ROUGE, LA, 70801.
Over the last 21 years, insiders at Albemarle have traded over $144,357,537 worth of Albemarle stock and bought 92,335 units worth $6,391,241 . The most active insiders traders include John J Nicols, Luther C Iv Kissam y Mark C Rohr. On average, Albemarle executives and independent directors trade stock every 16 days with the average trade being worth of $1,331,731. The most recent stock trade was executed by Mark Richard Mummert on 14 May 2024, trading 843 units of ALB stock currently worth $114,252.
albemarle corporation, headquartered in baton rouge, louisiana, is a premier specialty chemicals company with leading positions in attractive end markets around the world. with a broad customer reach and diverse end markets, albemarle develops, manufactures and markets technologically advanced and high value added products, including lithium and lithium compounds, bromine and derivatives, catalysts and surface treatment chemistries used in a wide range of applications including consumer electronics, flame retardants, metal processing, plastics, contemporary and alternative transportation vehicles, refining, pharmaceuticals, agriculture, construction and custom chemistry services. albemarle is focused on delivering differentiated, performance-based technologies that deliver innovative and sustainable solutions to its customers. the company employs approximately 6,900 people and serves customers in approximately 100 countries. albemarle regularly posts information to www.albemarle.com,
Albemarle executives and other stock owners filed with the SEC include: